chartexchange

Phathom Pharmaceuticals to Participate in November Investor Conferences

GlobeNewswire Inc. | Nov 4, 2026 8:00 AM EST

FLORHAM PARK, N.J., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on commercializing and developing novel treatments for gastrointestinal (GI) diseases, announced today that members of its management team are scheduled to participate in the following investor conferences:

Read original article